Your Medical AI Transformation Company
Empowering Precision Medicine with AI-Driven Innovation.
At STANOX.AI, we harness the power of cutting-edge artificial intelligence and machine learning to transform and advance multidisciplinary, tailored next-generation theranostics and targeted healthcare solutions — built on pioneering academic and scientific expertise rooted at Stanford and Oxford.
42+
Years of experience...
..through our
multidisciplinary founders
Trusted by global innovators
We unite academic excellence, high-end AI engineering, and translational science to deliver precision at scale. We are proud to collaborate with strong partners committed to our shared mission.
About Us
Driven by Science. Powered by AI. Focused on People.
At STANOX.AI, we believe the future of medicine lies at the intersection of biology and intelligence. Our interdisciplinary team combines expertise in computational biology, precision medicine, medical imaging, and multi-omics to accelerate the discovery of next-generation theranostics and targeted healthcare solutions.
OUR MISSION
We are more than a biotech company - we are a scientific partner committed to translating innovation into impact. By integrating artificial intelligence with real-world clinical data, we help pharma, biotech, research and healthcare institutions uncover customized AI-patterns that lead to better outcomes and faster breakthroughs.
Company Trailer
OUR VISION
To redefine how disease is understood, detected, and treated - empowering precision medicine worldwide.
OUR VALUES
- Integrity in Science Rigor, transparency, and evidence-based innovation.
- Collaboration Partnering with research, industry and institutions to amplify discovery.
- Impact Delivering tailored solutions that improve lives and shape the future of patient care.
Pipeline & Services
Leading innovation across critical fields of precision medicine
Each vertical is supported by expert teams and cutting-edge technologies, ensuring precision, innovation, and real-world relevance. Our work is rooted in curiosity, driven by data, and designed to deliver meaningful impact.
By combining advanced analytics with biological expertise, we identify disease-driving targets and biomarkers that connect diagnostics to therapy. This enables patient-tailored strategies and accelerates the development of precision theranostics.
We transform pathology into a data-rich source of clinical insights. Our AI models analyze tissue morphology at scale, uncovering subtle patterns that guide accurate diagnosis, risk stratification, and therapeutic decision-making.
Frequently Asked Questions
Browse our most asked questions
We've compiled answers to the most common questions about our services.
STANOX.AI develops AI-powered solutions to accelerate research, diagnostics, and therapeutic development. We combine biological sciences with advanced artificial intelligence to enable more precise medical insights and better patient outcomes.
Our AI identifies disease-relevant targets, biomarkers, and patterns that can be linked to diagnostics and therapy. This accelerates and enhances the precision of next-generation theranostic development.
Yes. Upon request, we train models exclusively on your proprietary data — fully confidential and isolated.
Our models analyze digital histopathology images and detect microscopic patterns that provide insights into diagnosis, prognosis, and treatment response.
PET, CT, MRI, as well as functional and radiomic parameters.
Yes. We build complete end-to-end solutions for research, clinical studies, precision medicine, biomarker discovery, and diagnostics.
Through encryption, GDPR-compliant processing, access restrictions, audit logs, and optionally isolated server environments.
News
Stay updated with latest in technologies, cooperations and our founders
Stanox.ai Enters Strategic, Synergistic Partnership with Nakamir
Stanox.ai is pleased to announce a strategic and highly synergistic partnership with the Silicon Valley-based company Nakamir.
Publication of a new peer-reviewed research article
We are proud to announce the publication of a new peer-reviewed research article in Acta Neuropathologica Communications.
More exciting news to come
Stay tuned for upcoming announcements about new partnerships, publications, and innovations.